Back to Search
TODD HULGAN, MD
MD
Infectious Disease Physician
NPI: 1740377878Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD34279(TN)
Research & Publications (20)
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.
PMID 18419350·J Infect Dis·2008
4-observational
High-concentration capsaicin reduced pain in patients with HIV-associated polyneuropathy.
PMID 19043041·Evid Based Med·2008
8-other
Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
PMID 17205482·J Infect Dis·2007
4-observational
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
PMID 16791116·J Acquir Immune Defic Syndr·2006
8-other
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.
PMID 16103764·AIDS·2005
4-observational
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
PMID 16107946·J Infect Dis·2005
8-other
Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons.
PMID 15735444·J Acquir Immune Defic Syndr·2005
8-other
Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention.
PMID 15367178·J Intern Med·2004
8-other
Oxidant stress is increased during treatment of human immunodeficiency virus infection.
PMID 14689356·Clin Infect Dis·2003
8-other
Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.
PMID 14526200·J Acquir Immune Defic Syndr·2003
8-other
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators.
PMID 19108987·J Clin Epidemiol·2009
8-other
Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.
PMID 19374518·Pharmacogenomics·2009
8-other
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care.
PMID 19220139·J Infect Dis·2009
8-other
Sociodemographic factors predict early discontinuation of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
PMID 19110909·J Natl Med Assoc·2008
8-other
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.
PMID 17684475·Pharmacogenomics J·2008
2-rct
Human genomic association studies: a primer for the infectious diseases specialist.
PMID 17492588·J Infect Dis·2007
6-review
Agreement of decision analyses and subsequent clinical studies in infectious diseases.
PMID 17466659·Am J Med·2007
8-other
Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
PMID 17465678·PLoS Pathog·2007
8-other
Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
PMID 17083029·J Infect Dis·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1310 24TH AVE S
NASHVILLE, TN 37212 - Phone
- (615) 327-4751
Quick Facts
- NPI
- 1740377878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile